Abstract
High-quality evidence shows that low-dose chest computed tomography (CT) screening effectively reduces lung cancer–related deaths in patients who smoked heavily.1 Compared with many other cancer screening modalities, this approach will be expensive,2 but whether it will be cost-effective is unknown. In the September 2015 issue of JAMA Oncology, Goffin et al3 estimate the cost-effectiveness of CT screening for lung cancer in Canada. This study is timely because it comes in the wake of the US National Lung Screening Trial (NSLT) and widespread availability of CT screening insurance coverage in the United States. The Canadian government has not yet implemented CT screening and often considers cost-effectiveness prior to making coverage decisions for new technologies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
